Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | CES2 | O00748 | 4/20 | 0.39 |
| ▸ | CES1 | P23141 | 4/20 | 0.39 |
| ▸ | BCHE | P06276 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.34 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.34 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | ALB | P02768 | 1/20 | 0.33 |
| ▸ | G6PD | P11413 | 1/20 | 0.33 |
| ▸ | CASP7 | P55210 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10800604 | 0.93 | ALDH1A1 (0.50) | ALDH1A1ALOX15TSHRCES2CES1 | |
| SCHEMBL28269769 | 0.91 | ALDH1A1 (0.50) | ALDH1A1ALOX15TSHRCA12CA1 | |
| SCHEMBL1323054 | 0.85 | CA12 (0.50) | ALDH1A1ALOX15TSHRCA12CA1 | |
| SCHEMBL1846335 | 0.85 | ALDH1A1 (0.74) | ALDH1A1ALOX15TSHRCES2CES1 | |
| Hexane SCHEMBL27931599 | 0.85 | TSHR (0.46) | ALDH1A1ALOX15TSHRPOLBHSD17B10 | |
| SCHEMBL4921450 | 0.84 | ALDH1A1 (0.46) | ALDH1A1ALOX15TSHRHSD17B10HPGD | |
| SCHEMBL301550 | 0.84 | ALDH1A1 (0.46) | ALDH1A1ALOX15POLBHSD17B10KDM4E | |
| SCHEMBL31611275 | 0.84 | ALDH1A1 (0.46) | ALDH1A1ALOX15POLBHSD17B10KDM4E | |
| SCHEMBL9836255 | 0.84 | ALDH1A1 (0.65) | ALDH1A1ALOX15CES2CES1BCHE | |
| SCHEMBL4924666 | 0.84 | ALDH1A1 (0.46) | ALDH1A1ALOX15TSHRCES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 245 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12521683-B2 | Reverse osmosis composite membrane with an ultrathin desalting layer and preparation method thereof | VONTRON TECHNOLOGY CO., LTD. (CN) | 2026-01-13 | — | — | US | claimed |
| CN-118594274-A | Preparation method of reverse osmosis membrane and application of reverse osmosis membrane in sewage treatment | 巴克夫化学有限公司 | 2024-09-06 | — | — | CN | claimed |
| US-20240091718-A1 | REVERSE OSMOSIS COMPOSITE MEMBRANE WITH AN ULTRATHIN DESALTING LAYER AND PREPARATION METHOD THEREOF | VONTRON TECHNOLOGY CO., LTD. (CN) | 2024-03-21 | — | — | US | claimed |
| CN-115672033-A | Anti-pollution and oxidation-resistant reverse osmosis membrane and preparation method thereof | 万华化学集团股份有限公司 | 2023-02-03 | — | — | CN | claimed |
| US-10800883-B1 | Optically transparent polyimide aerogels | UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF NATIONAL AERONAUTICS AND SPACE ADMINISTRATION (US) | 2020-10-13 | — | — | US | claimed |
| US-10787569-B1 | Process for preparing aerogels from polyamides | UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF NATIONAL AERONAUTICS AND SPACE ADMINISTRATION (US) | 2020-09-29 | — | — | US | claimed |
| WO-2013005215-A2 | PHMG MODIFIED ANTIMICROBIAL AGENTS | STRAUSS WATER LTD. (IL) | 2013-01-10 | — | — | WO | claimed |
| EP-0773481-B1 | Photoconductive element containing polycarbonates crosslinked by aryltricarboxylic acids or their acid chlorides | OCE TECH BV (NL) | 2000-09-06 | — | — | EP | claimed |
| EP-0773481-A1 | Photoconductive element containing polycarbonates crosslinked by aryltricarboxylic acids or their acid chlorides | Océ-Nederland B.V. (NL) | 1997-05-14 | — | — | EP | claimed |
| EP-0699702-A2 | Reaction products of carbonyl compounds and dihydric phenols | THE DOW CHEMICAL COMPANY (US) | 1996-03-06 | — | — | EP | claimed |
| EP-0336999-A2 | Reactive posttreatment for gas separation membranes | L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE (FR) | 1989-10-18 | — | — | EP | claimed |
| EP-0313354-A1 | Reverse osmosis membranes and process for their production | PCI MEMBRANE SYSTEMS LIMITED (GB) | 1989-04-26 | — | — | EP | claimed |
| US-4704448-A | MOLDING MATERIALS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-11-03 | — | — | US | claimed |
| EP-4724532-A1 | REWORKABLE POLYSILOXANES FOR THERMAL INTERFACE MATERIALS | International Business Machines Corporation (US) | 2026-04-15 | — | — | EP | disclosed |
| US-12521683-B2 | Reverse osmosis composite membrane with an ultrathin desalting layer and preparation method thereof | VONTRON TECHNOLOGY CO., LTD. (CN) | 2026-01-13 | — | — | US | disclosed |
| US-12257294-B2 | Therapeutics for autoimmune disease: synthetic antigens | DANMARKS TEKNISKE UNIVERSITET (DK) | 2025-03-25 | — | — | US | disclosed |
| EP-0313354-A1 | Reverse osmosis membranes and process for their production | PCI MEMBRANE SYSTEMS LIMITED (GB) | 1989-04-26 | — | — | EP | disclosed |
| US-4720537-A | Branched copolyetherketones | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1988-01-19 | — | — | US | disclosed |
| EP-0229470-A1 | Branched copolyetherketones | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-07-22 | — | — | EP | disclosed |
| US-4409201-A | Pressure-resistant microcapsules with a polyamide shell and a polyurethane-polyurea inner mass and process for their manufacture | HOECHST AKTIENGESELLSCHAFT (DE) | 1983-10-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12257294-B2 | Therapeutics for autoimmune disease: synthetic antigens | SSB, HAVCR2, CD47 | ALDH1A1 3003/4885ALOX15 3085/4885TSHR 365/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.